Skip to main content
P.H. flag

Unofficial COVID-19 PH Tracker

Icon by icons8.com

disease.sh - Open Disease Data
Sourced data from Johns Hopkins University, the New York Times, Worldometers, and Apple reports to give you a comprehensive view of the data.

Image of Vicente G. Reyes

Developed by Vicente G. Reyes
A Self-Directed Learner, a Freelance Web Developer, a Volunteer Developer at Project Website, Moderator at DEV, & a Podcast host. www.vgreyes.com

  • Medication Class: IL-6 receptor agonist

    Trade Name(generic name): ['Actemra (tocilizumab)']

    Spnosor: Various

    Trial Phase: Phase 3

    Institution: Roche

  • Medication Class: Antirheumatic agent

    Trade Name(generic name): ['Bucillamine']

    Spnosor: Revive Therapeutics Ltd.

    Trial Phase: Phase 3

    Institution: Revive Therapeutics Ltd.

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Bamlanivimab (LY-CoV555)']

    Spnosor: Lilly, Operation Warp Speed

    Trial Phase: Phase 2/3

    Institution: Lilly, AbCellera

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['VIR-7831 (GSK4182136)']

    Spnosor: Vir Biotechnology, Inc.

    Trial Phase: Phase 2/3

    Institution: Vir Biotechnology, Inc., GSK

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Mavrilimumab']

    Spnosor: The Cleveland Clinic

    Trial Phase: Phase 2

    Institution: Kiniksa Pharmaceuticals

  • Medication Class: Antibody cocktail

    Trade Name(generic name): ['Casirivimab/imdevimab (REGN-COV2)']

    Spnosor: Regeneron

    Trial Phase: Phase 1/2/3

    Institution: Regeneron

  • Medication Class: Antiviral

    Trade Name(generic name): ['Galidesivir']

    Spnosor: NIAID

    Trial Phase: Phase 1b

    Institution: BioCryst Pharmaceuticals

  • Medication Class: Anticoagulant

    Trade Name(generic name): ['Heparin (UF and LMW)']

    Spnosor: Operation Warp Speed, University of Pittsburgh

    Trial Phase: Phase 2/3/4

    Institution: NHLBI

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['CT-P59']

    Spnosor: Celltrion

    Trial Phase: Phase 3

    Institution: Celltrion

  • Medication Class: Antiviral

    Trade Name(generic name): ['Veklury (remdesivir)']

    Spnosor: Gilead Sciences

    Trial Phase: Phase 2/3

    Institution: Gilead Sciences

  • Medication Class: Antiviral

    Trade Name(generic name): ['Avigan (favilavir/avifavir)']

    Spnosor: Various

    Trial Phase: Phase 2/3

    Institution: Fujifilm Toyama Chemical (as Avigan), Zhejiang Hisun Pharmaceutical

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['PRO 140 (leronlimab)']

    Spnosor: CytoDyn

    Trial Phase: Phase 2b/3

    Institution: CytoDyn

  • Medication Class: JAK inhibitor

    Trade Name(generic name): ['Olumiant, Baricinix (baricitinib)']

    Spnosor: Eli Lilly, NIAID

    Trial Phase: Phase 3/4

    Institution: Eli Lilly

  • Medication Class: Nitric oxide

    Trade Name(generic name): ['INOpulse']

    Spnosor: Bellerophon Therapeutics

    Trial Phase: Phase 3

    Institution: Bellerophon Therapeutics

  • Medication Class: Antihelmintic

    Trade Name(generic name): ['Ivermectin']

    Spnosor: Various

    Trial Phase: Phase 2/3

    Institution: Various

  • Medication Class: Biguanide

    Trade Name(generic name): ['Metformin (Glucophage, Glumetza, Riomet)']

    Spnosor: University of Minnesota

    Trial Phase: Phase 2/3

    Institution: University of Minnesota

  • Medication Class: Antiviral

    Trade Name(generic name): ['MK-4482']

    Spnosor: Ridgeback Biotherapeutics

    Trial Phase: Phase 2

    Institution: DRIVE, Ridgeback Biotherapeutics, Merck

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['AZD7442']

    Spnosor: AstraZeneca, BARDA

    Trial Phase: Phase 3

    Institution: AstraZeneca, Vanderbilt University Medical Center

  • Medication Class: HIV protease inhibitor

    Trade Name(generic name): ['Kaletra (lopinavir-ritonavir)']

    Spnosor: Various

    Trial Phase: Phase 2/4

    Institution: AbbVie

  • Medication Class: Glucocorticoid

    Trade Name(generic name): ['Dexamethasone (Dextenza, Ozurdex, others)']

    Spnosor: University of Oxford

    Trial Phase: Phase 2/3

    Institution: Various

  • Medication Class: Antigout agent

    Trade Name(generic name): ['Colchicine (Mitigare, Colcrys)']

    Spnosor: Montreal Heart Institute

    Trial Phase: Phase 2/3

    Institution: NHLBI, Bill and Melinda Gates Foundation, Government of Quebec

  • Medication Class: Dihydroorotate dehydrogenase (DHODH) inhibitor

    Trade Name(generic name): ['PTC299']

    Spnosor: PTC

    Trial Phase: Phase 2/3

    Institution: PTC

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Lenzilumab']

    Spnosor: NIAID

    Trial Phase: Phase 3

    Institution: Humanigen, Catalent

  • Medication Class: Synthetic human vasoactive intestinal peptide (VIP)

    Trade Name(generic name): ['RLF-100 (aviptadil)']

    Spnosor: NeuroRx

    Trial Phase: Phase 2/3

    Institution: NeuroRx, Relief Therapeutics

  • Medication Class: Antiviral

    Trade Name(generic name): ['AT-527']

    Spnosor: Atea Pharmaceuticals, Inc.

    Trial Phase: Phase 2

    Institution: Atea Pharmaceuticals, Inc.

  • Medication Class: Anthelmintic

    Trade Name(generic name): ['Niclocide (niclosamide)']

    Spnosor: Tufts Medical Center, First Wave Bio, Inc., Lille University Hospital

    Trial Phase: Phase 2/3

    Institution: ANA Therapeutics

  • Medication Class: Immunoglobulin

    Trade Name(generic name): ['Convalescent plasma']

    Spnosor: Various

    Trial Phase: Phase 1/2

    Institution: Various

  • Medication Class: H2 blocker

    Trade Name(generic name): ['Pepcid (famotidine)']

    Spnosor: Northwell Health

    Trial Phase: Phase 3

    Institution: Yamanouchi Pharmaceutical Co., J&J, Merck

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Remicade (infliximab)']

    Spnosor: UHB, Birmingham National Institute for Health Research Biomedical Research Centre (NIHR BRC), NCATS, BARDA

    Trial Phase: Phase 2/3

    Institution: Janssen

  • Medication Class: Tyrosine kinase inhibitor

    Trade Name(generic name): ['STI-5656 (abivertinib)']

    Spnosor: Sorrento Therapeutics

    Trial Phase: Phase 2

    Institution: Sorrento Therapeutics

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['JS016']

    Spnosor: Lilly

    Trial Phase: Phase 1

    Institution: Lilly, Junshi Biosciences

  • Medication Class: IL-6 receptor agonist

    Trade Name(generic name): ['Kevzara (sarilumab)']

    Spnosor: Sanofi, Regeneron

    Trial Phase: No longer being studied for COVID-19

    Institution: Sanofi, Regeneron

  • Medication Class: Recombinant fusion protein

    Trade Name(generic name): ['SACCOVID (CD24Fc)']

    Spnosor: OncoImmune

    Trial Phase: Phase 3

    Institution: OncoImmune

  • Medication Class: Anti-TNF

    Trade Name(generic name): ['Humira (adalimumab)']

    Spnosor: COVID-19 Therapeutics Accelerator

    Trial Phase: Phase 2

    Institution: University of Oxford

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['COVI-GUARD (STI-1499)']

    Spnosor: Sorrento Therapeutics

    Trial Phase: Phase 1

    Institution: Sorrento Therapeutics

  • Medication Class: VIP receptor agonist

    Trade Name(generic name): ['PB1046']

    Spnosor: PhaseBio

    Trial Phase: Phase 2

    Institution: PhaseBio

  • Medication Class: Small-molecule inhibitor

    Trade Name(generic name): ['PF-00835321 (PF-07304814)']

    Spnosor: Pfizer

    Trial Phase: Phase 1b

    Institution: Pfizer

  • Medication Class: Anticoagulant

    Trade Name(generic name): ['Eliquis (Apixaban)']

    Spnosor: Operation Warp Speed

    Trial Phase: Phase 3

    Institution: NHLBI

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Takhzyro (lanadelumab)']

    Spnosor: Takeda (Shire)

    Trial Phase: Phase 1b

    Institution: Takeda (Shire)

  • Medication Class: Glucocorticoid

    Trade Name(generic name): ['Hydrocortisone']

    Spnosor: Various

    Trial Phase: Phase 3

    Institution: Various

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Ilaris (canakinumab)']

    Spnosor: Novartis

    Trial Phase: Phase 3

    Institution: Novartis

  • Medication Class: Small-molecule protein inhibitor

    Trade Name(generic name): ['BLD-2660']

    Spnosor: Blade Therapeutics

    Trial Phase: Phase 2

    Institution: Blade Therapeutics

  • Medication Class: Recombinant human plasma

    Trade Name(generic name): ['Rhu-pGSN (gelsolin)']

    Spnosor: BioAegis Therapeutics

    Trial Phase: Phase 2

    Institution: BioAegis Therapeutics

  • Medication Class: Angiotensin-(1–7) peptide

    Trade Name(generic name): ['TXA127']

    Spnosor: Columbia University Irving Medical Center

    Trial Phase: Phase 2

    Institution: Constant Therapeutics

  • Medication Class: PIKfyve inhibitor

    Trade Name(generic name): ['LAM-002A (apilimod dimesylate)']

    Spnosor: AI Therapeutics, Inc., Yale University

    Trial Phase: Phase 2

    Institution: AI Therapeutics, Inc.

  • Medication Class: RIPK1 inhibitor

    Trade Name(generic name): ['DNL758 (SAR443122)']

    Spnosor: Sanofi

    Trial Phase: Phase 1b

    Institution: Sanofi, Denali Therapeutics

  • Medication Class: HIV-1 Rev protein inhibitor

    Trade Name(generic name): ['ABX464']

    Spnosor: Abivax

    Trial Phase: Phase 2b/3

    Institution: Abivax

  • Medication Class: Autologous adipose-derived stem cells

    Trade Name(generic name): ['AdMSCs']

    Spnosor: Celltex Therapeutics

    Trial Phase: Phase 2

    Institution: Celltex Therapeutics

  • Medication Class: Mitogen-activated protein kinase (MAPK) inhibitor

    Trade Name(generic name): ['Losmapimod']

    Spnosor: Fulcrum Therapeutics

    Trial Phase: Phase 3

    Institution: Fulcrum Therapeutics

  • Medication Class: Kinase inhibitor

    Trade Name(generic name): ['Calquence (acalabrutinib)']

    Spnosor: AstraZeneca

    Trial Phase: Phase 2

    Institution: AstraZeneca

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Gimsilumab']

    Spnosor: Roivant Sciences

    Trial Phase: Phase 2

    Institution: Roivant Sciences

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Otilimab']

    Spnosor: GSK

    Trial Phase: Phase 2

    Institution: MorphoSys, GSK

  • Medication Class: Oral sodium-glucose co-transporter 2 (SGLT2) inhibitor

    Trade Name(generic name): ['Farxiga (dapagliflozin)']

    Spnosor: AstraZeneca

    Trial Phase: Phase 3

    Institution: Bristol-Myers Squibb

  • Medication Class: Monoclonal antibody

    Trade Name(generic name): ['Ultomiris (ravulizumab)']

    Spnosor: Alexion

    Trial Phase: Phase 3

    Institution: Alexion